Explore the future of healthcare transformation guided by Dawn Sherman, CEO of LabConnect, a trailblazer in clinical trials. The dialogue extends to the synergy of Quantum Computing and Artificial Intelligence, revolutionising conventional trial approaches. Delving into the profound implications of rejuvenation technologies, Don contemplates their societal impact. Join this conversation for a profound journey into healthcare innovation, leadership, and the evolving landscape of clinical trials.
[00:10] - About Dawn Sherman
Dawn is the CEO of LabConnect.
She has held various leadership positions in companies such as ProPharma Group, EnvisionRxOptions, Teva Pharmaceuticals, Medco Health Solutions, and Hay Group.
She also serves on several boards within the life sciences focused on services to pharmaceutical, biotechnology, and medical device companies.
The Brand Called You